Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se
FDA inspection history in Ocala, Florida, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Ocala, Florida.
Cited most
Across all Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se observations on file
- 21 CFR 312.62Investigator recordkeeping and record retention2
- 21 CFR 312.60General responsibilities of investigators1
- 21 CFR 312.64Investigator reports1
The complete Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ocala, Florida
One Form 483 · 2025 · 4 observations
Latest: Form 483, Sep 16, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-09-16 | 483 Form 483 | Ocala, Florida | 4 | $99 |
Investigators on these documents
FEI number 3038258929 · most recent document Sep 16, 2025
About Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se
How many FDA Form 483s has Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se received?
FDA Intel has 1 Form 483 on file for Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se; the most recent is dated Sep 16, 2025.
When was Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se last inspected by FDA?
The most recent FDA inspection document on file for Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se is a Form 483 dated Sep 16, 2025, for the site in Ocala, Florida.
What did FDA cite at Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se?
The regulations cited most in the observations on file for Lan Luo, M.D. Ocala Cardiovascular Research, 2801 Se are 21 CFR 312.62 (Investigator recordkeeping and record retention), 2 times; 21 CFR 312.60 (General responsibilities of investigators), 1 time; 21 CFR 312.64 (Investigator reports), 1 time.